What's breaking now, across thousands of outlets.
Etcamah is the second oral “SERD” to recently fall short in first-line breast cancer, following a similar setback from Roche earlier this year.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Google is loading its cheapest fitness tracker, the Google Fitbit Air, with premium tools from its Pixel Watch series to stay competitive.
Justice Swarana Kanta Sharma ruled that the company had failed to establish that any substantial or material part of the cause of action had arisen in Delhi.
(MedPage Today) -- The Trump administration's announcement that it will send $500 "rebate" checks to roughly 1 million Affordable Care Act (ACA) enrollees in 30 states ($500 million total) fits a…
Ghana's hard-won progress in maternal health could stall unless deliberate incentives are introduced to retain health workers in remote parts of the country, the Regional Director for West and Central…
(MedPage Today) -- Blockbuster GLP-1 receptor agonists revolutionized obesity management in recent years, driving weight loss of up to 20%.
